Important Safety Information Prescribing Information Print This Page
Sign up for updates

About CAVERJECT

CAVERJECT (alprostadil for injection) is a shot (injection therapy) that you take for erectile dysfunction (ED). It is used when the nerves or blood vessels in the penis do not work normally. Did you know? According to the AUA (American Urological Association), injection therapy is among the most effective nonsurgical treatment options for ED.1

Join the thousands of men who are having sex lives again because:

  • It works fast — CAVERJECT can give you an erection in just 5 to 20 minutes
  • You inject it yourself — The first shot will be given in your healthcare provider's office. After that, you can inject CAVERJECT, or your partner can help you inject
  • It is a local injection — CAVERJECT contains the ingredient alprostadil. It is a substance that is found in your body. It helps keep blood vessels open and your blood flowing

When using CAVERJECT:

  • Do not use more than 3 times a week
  • Wait at least 24 hours between doses
  • Do not change the dose without talking to your healthcare provider
  • Do not use any leftover solution
  • Do not reuse the syringe or needle
  • Do not let anyone else use your CAVERJECT
  • Do not stop taking any prescription medications unless your healthcare provider tells you to do so
  • If you have been advised not to have sex, do not use CAVERJECT
  • If you have an erection lasting more than 4 hours after injection, contact your healthcare provider right away

1.American Urological Association Education and Research, Inc. 2005; p12.
http://www.auanet.org/content/guidelines-and-quality-care/clinical-guidelines/main-reports/edmgmt/chapter1.pdf
Accessed 6/10/2010.



CAVERJECT is used to treat erectile dysfunction (ED) due to neurogenic, vasculogenic, psychogenic, or mixed etiology.


Important Safety Information

CAVERJECT should not be used in men hypersensitive to alprostadil, men with conditions that may predispose them to priapism (such as sickle cell anemia or trait, multiple myeloma or leukemia), men with anatomical deformities of the penis (such as angulation, cavernosal fibrosis or Peyronie’s disease), men with penile implants, or men for whom sexual activity is inadvisable or is contraindicated.

CAVERJECT should not be used in women, children or newborns.

Patients should be instructed to immediately report to his physician any erection lasting 4 hours or longer. If unavailable, patient must seek immediate medical assistance.

CAVERJECT can cause penile fibrosis or Peyronie’s disease.

Use of Caverject in patients who take anticoagulants, such as warfarin or heparin, should be with precaution as they may have increased tendency for bleeding after Caverject injections.

The most common side effect of CAVERJECT® (alprostadil for injection) was penile pain, reported by 37% of patients in clinical studies. Other side effects were prolonged erection, penile fibrosis and injection site hematoma. To lower the risk of prolonged erections or priapism, Caverject should be titrated slowly to the lowest effective dose.

For Full Prescribing Information for CAVERJECT®, including Instructions for Use, please click here.